News

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.
British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump ...
The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several ...
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...
AstraZeneca said the “cornerstone” of the commitment would be a new weight management production facility for its oral GLP-1 ...
The biopharmaceutical company said the investment includes plans for a new manufacturing center focused on chronic diseases.
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030.
That’s how long it took from the time AstraZeneca CEO Pascal Soriot greeted Virginia Governor Glenn Youngkin in his London ...
In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...
The announcement by AstroZeneca follows a growing trend of companies pledging to invest in pharmaceutical manufacturing on ...
AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.
AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a ...